Detalhe da pesquisa
1.
Machine learning approach informs biology of cancer drug response.
BMC Bioinformatics
; 23(1): 184, 2022 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581546
2.
A simplified transposon mutagenesis method to perform phenotypic forward genetic screens in cultured cells.
BMC Genomics
; 20(1): 497, 2019 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31208320
3.
Understanding cancer drug resistance with Sleeping Beauty functional genomic screens: Application to MAPK inhibition in cutaneous melanoma.
iScience
; 26(10): 107805, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37860756
4.
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas.
NPJ Precis Oncol
; 6(1): 74, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271142
5.
Src-Dependent DBL Family Members Drive Resistance to Vemurafenib in Human Melanoma.
Cancer Res
; 79(19): 5074-5087, 2019 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31416844
6.
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.
J Mol Diagn
; 19(5): 682-696, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28802831
7.
Cancer Driver Log (CanDL): Catalog of Potentially Actionable Cancer Mutations.
J Mol Diagn
; 17(5): 554-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26320871